2021 JUDGING CRITERIA

1. In-Market: Is the solution purchasable by patients, payers or providers?
‍
2. Functionality: What specific outcomes are you improving and does the product or the solution deliver them?
‍
‍3. Validation: Does the product or the solution really work? Is it FDA approved? Does it have verifiable success stories and customer testaments to its efficacy?
‍
‍4. Customer Traction: Is the product or the solution widely used, and how impactful is it to the patient?

1. Innovation: Does the product or the solution introduce a new capability of significant improvement?

2. Impact: How has the product or the solution helped improve the standard of care and improved patient outcomes while improving user satisfaction?

‍3. Value: Does the product or the solution help reduce the overall cost of healthcare and is it cost-effective?

1. Reimbursement: Is the product or the solution reimbursed by a national or private insurance payor?

2. Evidence: What evidence of benefit has the product or the solution established? Has it been validated by a clinical trial or a research study?

‍3. Differentiation: Does the product or the solution represent a true breakthrough in the cluttered market by providing a totally new or more useful functionality than other solutions?

1. Unmet need: How large is the patient unmet need for this drug, drug candidate or platform technology? How big of an impact will this technology have on these patients?
‍
‍2. Validation: Are there any strategic partnerships or peer-reviewed publications that validate this technology? Is there significant strength in the scientific advisory board?
‍
‍3. Track Record: Does the company have a track record of successful execution on preclinical, clinical and/or commercial milestones?

1. Innovation: Does the drug, drug candidate or platform technology represent a new approach or modality, or an clinical improvement on an existing product or technology?

2. Impact: Is the company advancing either a first-in-class or best-in-class product?

‍3. Value: How does the product or technology improve patient outcomes while reducing cost-burden to the healthcare system?

1. Evidence: What preclinical, clinical and/or real world evidence exists to support the safety and efficacy?

‍2. Speed to Market: If not already, how quickly can patients experience the impact from these technologies?

3. Groundbreaking: Will this drug, drug candidate or platform technology disrupt the treatment paradigm for diseases of high unmet need or global health crises?